KARACHI: The National University of Singapore has awarded the "Research Excellence Award 2025" to the Dow Institute of Biological Biochemical and Pharmaceutical Sciences (IBBPS) for its outstanding success in research aimed at reducing mortality rates related to antimicrobial resistance (AMR).
This award is a significant achievement for Dow-IBBPS in the field of research Recently, DUHS Institution, IBBPS concluded “A Clinically-Oriented Antimicrobial Resistance Surveillance Network for Healthcare-associated infections (ACORN-HAI)” study.
The study’s focus on Bloodstream Infections (BSI) and Ventilator-Associated Pneumonia (VAP) with Hospital Acquired Infection. Dow-IBBPS completed global surveillance study on AMR (Antimicrobial Resistance) in collaboration with National University of Singapore (NUS) with globally 41 clinical trial active sites.
This study may bring new interventions in future so to reduce the mortality rate which accounts almost 25% as per recent studies.
Initially, this seems challenging for low- and middle-income countries (LMICs) to conduct surveillance as it requires trained manpower and resources; However through relentless efforts, made this possible. It is a ground work for subsequent interventional clinical trials targeting MDR infections so to minimize AMR.
